Column GROUP Iii-a, L.P., 10% Owner at NGM BIOPHARMACEUTICALS INC (NGM), bought 120,223 shares at $13.43 ($1.6M) on 2022-05-25, disclosed to the SEC on 2022-05-26.
Open-market purchase of $1.6M NGM by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.37 | 588 | $8K | 0.5% |
| 2 | $13.37 | 17,240 | $230K | 14.3% |
| 3 | $13.37 | 17,240 | $230K | 14.3% |
| 4 | $13.43 | 1,429 | $19K | 1.2% |
| 5 | $13.43 | 41,863 | $562K | 34.9% |
| 6 | $13.43 | 41,863 |
| $562K |
| 34.9% |
| Total | $13.41 avg | 120,223 | $1.6M | 100% |
| Filing → |
| SRZN | BUY | 2024-04-17 | $6.0M | — | Filing → |
| TNYA | BUY | 2024-02-14 | $10.0M | — | Filing → |
| TNYA | BUY | 2023-02-10 | $3.9M | — | Filing → |